Pharmacokinetics Study of ALO-02 and OxyContin

NCT01557257 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Management of Moderate to Severe Pain

Interventions

DRUG: ALO-02
DRUG: Naltrexone block
DRUG: ALO-02
DRUG: Naltrexone block
DRUG: OxyContin
DRUG: Naltrexone block

Sponsor

Pfizer